NASP Co-signs letter to President Trump on to Commission on Containing Costs of Lifesaving Prescription Drugs

NASP Co-signs letter to President Trump on to Commission on Containing Costs of Lifesaving Prescription Drugs

A myriad of stakeholders across the health care industry, including the National Association of Specialty Pharmacy (NASP), joined together to send a letter to U.S. President Donald Trump, encouraging him to appoint Rep. Earl L. “Buddy” Carter (GA-1) to any commission formed to address the cost of lifesaving prescription medications in the U.S.

Click here to view the press release.

Comments are closed.